208 related articles for article (PubMed ID: 37373743)
1. CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation.
Wlodarczyk B; Durko L; Wlodarczyk P; Talar-Wojnarowska R; Malecka-Wojciesko E
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373743
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes.
Włodarczyk B; Borkowska A; Włodarczyk P; Małecka-Panas E; Gąsiorowska A
Prz Gastroenterol; 2021; 16(1):36-42. PubMed ID: 33986886
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of insulin-like growth factor (IGF-1) and retinol binding protein (RBP-4) levels in patients with newly diagnosed pancreatic adenocarcinoma (PDAC).
Wlodarczyk B; Gasiorowska A; Borkowska A; Malecka-Panas E
Pancreatology; 2017; 17(4):623-628. PubMed ID: 28499807
[TBL] [Abstract][Full Text] [Related]
4. Serum Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor-binding Protein 2 as a Novel Biomarker in the Detection of Pancreatic Adenocarcinoma.
Wlodarczyk B; Borkowska A; Wlodarczyk P; Malecka-Panas E; Gasiorowska A
J Clin Gastroenterol; 2020 Oct; 54(9):e83-e88. PubMed ID: 31851103
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
[TBL] [Abstract][Full Text] [Related]
6. Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma.
Kozak A; Talar-Wojnarowska R; Kaczka A; Borkowska A; Czupryniak L; Małecka-Panas E; Gąsiorowska A
World J Gastrointest Oncol; 2016 Aug; 8(8):635-41. PubMed ID: 27574557
[TBL] [Abstract][Full Text] [Related]
7. Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis.
Moutinho-Ribeiro P; Adem B; Batista I; Silva M; Silva S; Ruivo CF; Morais R; Peixoto A; Coelho R; Costa-Moreira P; Lopes S; Vilas-Boas F; Durães C; Lopes J; Barroca H; Carneiro F; Melo SA; Macedo G
Dig Liver Dis; 2022 Jul; 54(7):871-877. PubMed ID: 34840127
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
9. Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer.
Karna E; Surazynski A; Orłowski K; Łaszkiewicz J; Puchalski Z; Nawrat P; Pałka J
Int J Exp Pathol; 2002 Oct; 83(5):239-45. PubMed ID: 12641820
[TBL] [Abstract][Full Text] [Related]
10. Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
Ulinski T; Mohan S; Kiepe D; Blum WF; Wingen AM; Mehls O; Tönshoff B
Pediatr Nephrol; 2000 Jul; 14(7):589-97. PubMed ID: 10912524
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation.
Weber MM; Auernhammer CJ; Lee PD; Engelhardt D; Zachoval R
Horm Res; 2002; 57(3-4):105-12. PubMed ID: 12006706
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
13. Serum IGF-binding protein-6 and prostate specific antigen in breast cancer.
Kaulsay KK; Ng EH; Ji CY; Ho GH; Aw TC; Lee KO
Eur J Endocrinol; 1999 Feb; 140(2):164-8. PubMed ID: 10069662
[TBL] [Abstract][Full Text] [Related]
14. Growth promoting peptides in diabetic and non-diabetic pregnancy: interactions with trophoblastic receptors and serum carrier proteins.
Culler FL; Tung RF; Jansons RA; Mosier HD
J Pediatr Endocrinol Metab; 1996; 9(1):21-9. PubMed ID: 8887130
[TBL] [Abstract][Full Text] [Related]
15. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
Helm O; Mennrich R; Petrick D; Goebel L; Freitag-Wolf S; Röder C; Kalthoff H; Röcken C; Sipos B; Kabelitz D; Schäfer H; Oberg HH; Wesch D; Sebens S
PLoS One; 2014; 9(5):e94357. PubMed ID: 24797069
[TBL] [Abstract][Full Text] [Related]
16. Circulating insulin-like growth factor binding protein-4 (IGFBP-4) is not regulated by parathyroid hormone and vitamin D in vivo: evidence from children with rickets.
Bereket A; Cesur Y; Özkan B; Adal E; Turan S; Onan SH; Döneray H; Akçay T; Haklar G
J Clin Res Pediatr Endocrinol; 2010; 2(1):17-20. PubMed ID: 21274331
[TBL] [Abstract][Full Text] [Related]
17. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
[TBL] [Abstract][Full Text] [Related]
18. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
[TBL] [Abstract][Full Text] [Related]
19. Comparison of platelet-lymphocyte ratio and CA 19-9 in differentiating benign from malignant head masses in patients with chronic pancreatitis.
Kakkat S; Rajan R; Sindhu RS; Natesh B; Raviram S
Indian J Gastroenterol; 2017 Jul; 36(4):263-267. PubMed ID: 28916969
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
